Decision: Favourable

Decisions Table

Study Title:

Clinical Performance Study Plan for FoundationOne CDX (F1CDx) used as a Clinical Trial Assay (CTA) in the Clinical Trial XPORT-EC-042 for Karyopharm Therapeutics Inc.

  • NREC Code:

    23-NREC-MD-023

  • Decision:

    Favourable

  • Meeting Date:

    20/07/2023

  • Study Type:

    MD Application

  • Principal Investigator:

    Dr Dearbhaile Collins

  • PI Institution:

    Cork University Hospital

  • Sponsor:

    Karyopharm Therapeutics Inc.

Scroll to Top